A Randomised Double-Blind, Placebo-Controlled Trial of Pramipexole in Addition to Mood Stabilisers for Patients with Treatment-Resistant Bipolar Depression (the PAX-BD Study) R. Hamish McAllister-Williams , Nicola Goudie , Lumbini Azim , Victoria Bartle , Michael Berger , Chrissie Butcher , Thomas Chadwick , Emily Clare , Paul Courtney , Lyndsey Dixon , Nichola Duffelen , Tony Fouweather , William Gann , John Geddes , Sumeet Gupta , Beth Hall , Timea Helter , Paul Hindmarch , Eva-Maria Holstein , Ward Lawrence , Phil Mawson , Iain Mckinnon , Adam Milne , Aisling Molloy , Abigail Moore , Richard Morriss , Anisha Nakulan , Judit Simon , Daniel Smith , Bryony Stokes-Crossley , Paul R. A. Stokes , Andrew Swain , Adeola Taiwo , Zoe Walmsley , Christopher Weetman , Allan H. Young , Stuart Watson JOURNAL OF PSYCHOPHARMACOLOGY（2025）
Key words
Pramipexole, bipolar depression, treatment resistance, randomised controlled trial
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
